SNOA earnings
Sonoma Pharmaceuticals (SNOA) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- SNOA reports next on Feb 16, 2027, with EPS of -0.09 expected.
- SNOA beat EPS estimates in 8 of its last 15 reports.
SNOA earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2027 | Nov 10, 2026 | -0.01 | -0.10 | 90.00% | $7.17M |
| Q1 2027 | Aug 6, 2026 | 0.02 | -0.30 | 106.67% | $6.41M |
| Q4 2026 | Jun 16, 2026 | -0.33 | -0.24 | -37.50% | $5.56M |
| Q2 2026 | Nov 4, 2025 | -0.32 | -0.31 | -3.23% | $5.60M |
| Q1 2026 | Aug 7, 2025 | -0.76 | -0.51 | -49.02% | $4.01M |
| Q4 2025 | Jun 17, 2025 | -0.15 | -0.73 | 79.18% | $3.75M |
| Q3 2025 | Feb 5, 2025 | -0.59 | -0.80 | 25.69% | $3.56M |
| Q2 2025 | Nov 7, 2024 | -0.59 | -0.80 | 26.25% | $3.58M |
| Q1 2025 | Aug 8, 2024 | -1.40 | -1.00 | -40.00% | $3.39M |
| Q4 2024 | Jun 17, 2024 | -0.07 | -3.41 | 97.95% | $3.44M |
| Q3 2024 | Feb 8, 2024 | -0.08 | -0.21 | 61.90% | $3.14M |
| Q2 2024 | Nov 13, 2023 | -4.00 | -3.78 | -5.92% | $2.73M |
| Q1 2024 | Aug 10, 2023 | -5.80 | -2.40 | -141.67% | $3.43M |
| Q4 2023 | Jun 21, 2023 | -4.60 | 1.43 | -421.68% | $3.01M |
| Q3 2023 | Feb 14, 2023 | -10.00 | – | – | $2.94M |
| Q2 2023 | Nov 14, 2022 | -0.33 | -18.20 | 98.19% | $3.33M |